Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. bluebird bio, Inc.
EIR
•bluebird bio, Inc.•May 6, 2022

bluebird bio, Inc. – FDA EIR, May 6, 2022

Record Details

An FDA Good Clinical Practice (GCP) sponsor inspection was conducted at bluebird bio, Inc. from April 29 to May 6, 2022, in Cambridge, MA. This high-priority, surveillance inspection, initiated by the FDA's Center for Biologics Evaluation and Research, assessed bluebird bio's responsibilities for clinical study protocols supporting a Biologics License Application, under Compliance Program 7348.810 for Sponsors and Contract Research Organizations. While no formal inspectional observations (Form FDA 483) were issued, two key issues were identified and discussed with company management. Firstly, inactivated log lines in a study database were not appearing in generated casebook PDFs. In response, bluebird bio committed to creating and distributing new casebooks that include these inactivated log lines to clinical sites. Secondly, casebooks for another study lacked an audit trail for source data verification (SDV), meaning there was no clear documentation of who performed the verification and when, thus not adhering to ALCOA principles (attributable, legible, contemporaneous, original, and accurate). Management acknowledged this and explained that while the affected database is decommissioned and cannot be updated, their current platform for new studies incorporates comprehensive audit trails for SDV. No further preventative actions were deemed implementable for the specific historical database issue.

Company
bluebird bio, Inc.
Inspection date
May 6, 2022
Product type
biologics
Office
New England District Office
Person
  • Kent A. Conforti (issuing_officer)
View Company Profile

ID · 4ca05c63-4f93-4518-a432-04e0e2c9c8bc

Violation Codes5
21 CFR 312.3221 CFR 21121 CFR 312.321 CFR 1121 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for bluebird bio, Inc.
  • 483 - 2025-03-20March 20, 2025
  • EIR - 2021-03-09March 9, 2021
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore bluebird bio, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.